NHS prescribing requires strict eligibility criteria
These products are not evaluated or regulated in the same way as prescription GLP-1 medications, and there is limited clinical data on their effects on pancreatic enzymes or long-term pancreatic health
OReilly MW, House PJ, Tomlinson JW
The goal is to follow children over years or decades to create evidence about long-term effects
CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin
The small-molecule nature of orforglipron provides manufacturing advantages (conventional chemical synthesis rather than peptide synthesis), stability advantages (no cold chain required, room temperature storage), and formulation flexibility (simple oral tablet, no SNAC enhancer)